Palvella Therapeutics (@palvellatx) 's Twitter Profile
Palvella Therapeutics

@palvellatx

Palvella Therapeutics ($PVLA) is #biotech focused on novel therapies for patients with serious, rare genetic skin diseases w/ no FDA approved therapies.

ID: 955707785634775040

linkhttps://www.palvellatx.com calendar_today23-01-2018 07:44:27

111 Tweet

578 Takipçi

106 Takip Edilen

Palvella Therapeutics (@palvellatx) 's Twitter Profile Photo

We’re pleased that our Phase 2 results from our study of QTORINTM rapamycin in microcystic lymphatic malformations were recently published in the Journal of Vascular Anomalies. Please see our release to learn more bit.ly/4fQLTHg

We’re pleased that our Phase 2 results from our study of QTORINTM rapamycin in microcystic lymphatic malformations were recently published in the Journal of Vascular Anomalies. Please see our release to learn more bit.ly/4fQLTHg